Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European StudyUri Kopylov, Marc Ferrante, Yulia Ron et al.|Inflammatory Bowel Diseases|2018Cited by 70
Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER StudyPiotr Eder, Idan Goren, Bram Verstockt et al.|Journal of Crohn s and Colitis|2023Cited by 15
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case SeriesBrigida Barberio, Pierre Ellul, Edoardo Savarino et al.|Journal of Crohn s and Colitis|2022Cited by 8
DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn’s and Colitis Organisation studyUri Kopylov, Marc Ferrante, Bram Verstockt et al.|Journal of Crohn s and Colitis|2018Cited by 4